GW Henssler & Associates’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.3M Buy
21,482
+1,122
+6% +$589K 0.6% 69
2025
Q1
$12.9M Buy
20,360
+2,543
+14% +$1.61M 0.74% 59
2024
Q4
$18.7M Sell
17,817
-251
-1% -$264K 1.07% 41
2024
Q3
$19M Sell
18,068
-477
-3% -$501K 1.07% 41
2024
Q2
$19.5M Sell
18,545
-908
-5% -$954K 1.17% 38
2024
Q1
$18.7M Sell
19,453
-498
-2% -$479K 1.1% 42
2023
Q4
$17.5M Sell
19,951
-528
-3% -$464K 1.16% 39
2023
Q3
$16.9M Sell
20,479
-425
-2% -$350K 1.15% 38
2023
Q2
$15M Sell
20,904
-198
-0.9% -$142K 0.99% 48
2023
Q1
$17.3M Sell
21,102
-190
-0.9% -$156K 1.15% 42
2022
Q4
$15.4M Buy
21,292
+410
+2% +$296K 1.08% 40
2022
Q3
$14.4M Buy
20,882
+411
+2% +$283K 1.08% 41
2022
Q2
$12.1M Buy
20,471
+55
+0.3% +$32.5K 0.9% 49
2022
Q1
$14.3M Buy
20,416
+370
+2% +$258K 0.87% 50
2021
Q4
$12.7M Buy
20,046
+134
+0.7% +$84.6K 0.81% 55
2021
Q3
$12.1M Buy
19,912
+60
+0.3% +$36.3K 0.84% 55
2021
Q2
$11.1M Buy
19,852
+490
+3% +$274K 0.73% 61
2021
Q1
$9.16M Buy
19,362
+883
+5% +$418K 0.66% 63
2020
Q4
$8.93M Sell
18,479
-1,799
-9% -$869K 0.68% 58
2020
Q3
$11.4M Sell
20,278
-13,744
-40% -$7.69M 0.96% 50
2020
Q2
$21.2M Sell
34,022
-2,916
-8% -$1.82M 1.87% 10
2020
Q1
$18M Sell
36,938
-1,018
-3% -$497K 1.83% 12
2019
Q4
$14.3M Buy
37,956
+1,835
+5% +$689K 1.18% 32
2019
Q3
$10M Buy
36,121
+8,382
+30% +$2.33M 0.89% 47
2019
Q2
$8.68M Buy
+27,739
New +$8.68M 0.79% 55